0001974158-24-000001.txt : 20240105 0001974158-24-000001.hdr.sgml : 20240105 20240105160453 ACCESSION NUMBER: 0001974158-24-000001 CONFORMED SUBMISSION TYPE: 144 PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20240105 DATE AS OF CHANGE: 20240105 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: ESSA Pharma Inc. CENTRAL INDEX KEY: 0001633932 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 000000000 STATE OF INCORPORATION: A1 FISCAL YEAR END: 0930 FILING VALUES: FORM TYPE: 144 SEC ACT: 1933 Act SEC FILE NUMBER: 001-37410 FILM NUMBER: 24516216 BUSINESS ADDRESS: STREET 1: SUITE 720 STREET 2: 999 WEST BROADWAY CITY: VANCOUVER STATE: A1 ZIP: V5Z 1K5 BUSINESS PHONE: (778) 331-0962 MAIL ADDRESS: STREET 1: SUITE 720 STREET 2: 999 WEST BROADWAY CITY: VANCOUVER STATE: A1 ZIP: V5Z 1K5 REPORTING-OWNER: COMPANY DATA: COMPANY CONFORMED NAME: Virsik Peter CENTRAL INDEX KEY: 0001826322 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 144 MAIL ADDRESS: STREET 1: 131 ESCANYO WAY CITY: PORTOLA VALLEY STATE: CA ZIP: 94028 144 1 primary_doc.xml 144 0001826322 XXXXXXXX LIVE 0001633932 ESSA Pharma Inc. 001-37410 SUITE 720 999 WEST BROADWAY VANCOUVER A1 V5Z 1K5 (778) 331-0962 Virsik Peter Officer Common Jefferies LLC

520 Madison Ave New york NY 10022

2087 12876.79 20840000 01/05/2024 NASDAQ Common 07/29/2020 Directed Share Program Purchase ESSA Pharma Inc N 2087 07/29/2020 n/a Y All sales are to be made pursuant to a previously signed/adopted 10b5-1 selling plan dated August 28, 2023 and all representations regarding non-public information were made as of the adoption of the plan. 01/05/2024 08/28/2023 Peter Virsik